Manhattan Pharmaceuticals Reports Results for Six Months Ended June 30, 2006 and Reduced Loss for the Three Months Ended March 3, 2006
14 août 2006 08h30 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced financial results for the six months ended June 30, 2006. Net loss for the period was approximately...
Manhattan Pharmaceuticals to Present at 2nd Annual Obesity Drug Development Summit
19 juil. 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, chief medical officer, will present a scientific overview of oral...
Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer
10 juil. 2006 10h21 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Michael G. McGuinness joined the company as Chief Financial Officer, effective today. Mr....
Manhattan Pharmaceuticals to Present at CE Unterberg Towbin Emerging Growth Conference
05 juil. 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 5, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Ring Opening Bell At American Stock Exchange
07 juin 2006 10h09 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, June 7, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will ring the opening bell at the American...
Manhattan Pharmaceuticals to Present at Pacific Growth Equities Life Sciences Growth Conference
06 juin 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, June 6, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Present at Friedman Billings Ramsey 2006 Growth Investor Conference
24 mai 2006 08h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 24, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference, May 15-16, Monaco
10 mai 2006 10h22 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals Invited to Participate in Three Scientific Meetings On Obesity and Related Disorders
08 mai 2006 11h21 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 8, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today it has accepted invitations to participate in three upcoming scientific meetings focused on obesity and...
Manhattan Pharmaceuticals Reports Update on Clinical Development Programs
28 avr. 2006 16h10 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, April 28, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced the following update regarding the development status of oral Oleoyl-estrone for obesity and topical PTH...